Universities UK and Studiosity Strategic Partnership

Join over 250 institutions worldwide and put your institution at the global forefront of student experience

We are delighted to enter into a multi-year strategic partnership with Universities UK. This relationship is a great stride together in achieving our combined mission of creating the conditions for universities to thrive, and increasing life chances for students. 

Studiosity’s unique AI learning (not correcting) technology means all students can benefit from personalised formative feedback in minutes, including guidance on how they can demonstrably improve their own work and critical thinking skills. Actionable insight is accessible to faculty and leaders, revealing the scale of engagement with support, cohorts requiring intervention, and measurable learning progress. 

We can now offer all Universities UK members a pro bono trial for up to 2,000 students, plus a discounted price on an ongoing service starting next academic year. This trial is designed to provide you with a clear proof of concept for budgeting and incorporating Studiosity into your plans for the 2025/26 academic year. The trial costs will be fully funded by Studiosity. Leave your details in the short form, and we will share how evidenced student outcomes can be realised for you, at your university. To recap:

• Service: AI-for-Learning powered Studiosity.
• Cohort Size: Up to 2,000 students (ideally within one engaged faculty but open to discussion).
• Timeline: Assessment time now (March-May 2025)
• (Potential also to support your summer PSG and resit students)
• Support: Dedicated Partner Services Manager and technical specialist throughout the trial to support with set-up and the evaluation at the end of the trial.
• Access: LTI integration - can be live in two weeks: students must access via university's LMS; Studiosity access to faculty staff for training and engagement.
• Ongoing student support: UUK member significantly reduced rate to  seamlessly continue into the start of the new term.